LOVAZA (GlaxoSmithKline LLC)
Welcome to the PulseAid listing for the LOVAZA drug offered from GlaxoSmithKline LLC. This Fatty Acids, Omega-3 [Chemical/Ingredient],Omega-3 Fatty Acid [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | GlaxoSmithKline LLC |
| NON-PROPRIETARY NAME: | omega-3-acid ethyl esters |
| SUBSTANCE NAME: | OMEGA-3-ACID ETHYL ESTERS |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Fatty Acids, Omega-3 [Chemical/Ingredient],Omega-3 Fatty Acid [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE, LIQUID FILLED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2008-10-21 |
| END MARKETING DATE: | 0000-00-00 |
LOVAZA HUMAN PRESCRIPTION DRUG Details:
| Item Description | LOVAZA from GlaxoSmithKline LLC |
| LABELER NAME: | GlaxoSmithKline LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 900(mg/1) |
| START MARKETING DATE: | 2008-10-21 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0173-0783_228a0eaf-7cd6-4a61-a3e1-60d3a33cdcf5 |
| PRODUCT NDC: | 0173-0783 |
| APPLICATION NUMBER: | NDA021654 |
Other OMEGA-3-ACID ETHYL ESTERS Pharmaceutical Manufacturers / Labelers:
